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Gastrointestinal microbiota and immune cells interact closely and display regional 43 
specificity, but little is known about how these communities differ with location. Here, 44 
we simultaneously assess microbiota and single immune cells across the healthy, 45 
adult human colon, with paired characterisation of immune cells in the mesenteric 46 
lymph nodes, to delineate colonic immune niches at steady-state. We describe 47 
distinct T helper cell activation and migration profiles along the colon and 48 
characterise the transcriptional adaptation trajectory of T regulatory cells between 49 
lymphoid tissue and colon. Finally, we show increasing B cell accumulation, clonal 50 
expansion and mutational frequency from caecum to sigmoid colon, and link this to 51 
the increasing number of reactive bacterial species.  52 
 53 
Introduction: 54 
The colon, as a barrier tissue, represents a unique immune environment where 55 
immune cells display tolerance towards a diverse community of microbes - 56 
collectively known as the microbiome. The microbiome is critical for many aspects of 57 
health and an imbalance of commensals and pathogenic microbes is linked with 58 
many disease states 1. Thus, understanding what constitutes a healthy, homeostatic 59 
relationship between host immune cells and the microbiome of the human colon is of 60 
critical importance. At a coarse-grained level, intestinal microbiota and immunity 61 
have been studied extensively. Here, we provide an in-depth map of proximal-to-62 
distal changes in the colonic microbiome and host immune cells.  63 
 64 
The composition of the microbiota at any location in the intestines is determined by 65 
the availability of nutrients, oxygen and the transit rate of luminal content, and as 66 
 
4 
such, is spatially distinct 2. Regional differences are most evident when comparing 67 
the small intestine and distal colon in humans or other mammals 3,4. Within the colon, 68 
early studies identified changes from proximal (including the caecum, ascending and 69 
transverse colon) to distal colon (comprising the descending and sigmoid colon 70 
connecting to the rectum). Changes were evident with respect to the growth rates 71 
and activities of some bacteria species, which were dependent on nutrient availability 72 
4. A proximal-to-distal gradient of bacterial diversity in which the number of 73 
operational taxonomic units (OTU) increases has been reported 5.  74 
 75 
The intestinal immune system has a symbiotic relationship with the microbiome and 76 
is central to the maintenance of epithelial barrier integrity. The lamina propria and 77 
associated lymphoid tissues contain one of the largest and most diverse 78 
communities of immune cells - including both lymphocytes and myeloid cells 6. There 79 
is marked regional variation in immune cells along the gastrointestinal tract, with T 80 
helper (Th) 17 cells decreasing in number from duodenum to colon, and T regulatory 81 
(Treg) cells being highest in the colon 7. Whether there is further complexity, with 82 
distinct immunological niches, within the colon remains to be elucidated. Immune 83 
cells can respond to environmental cues including the microbiota. Mouse studies 84 
have demonstrated that specific bacterial species can fine-tune intestinal immune 85 
responses, including Th17 8,9, Treg 10, or Th1 11 polarisation and function 8,12 and B 86 
cell activation 13. However, the extent to which there is regional variation in the 87 
mucosal microbiome within an individual, and how this might influence local immune 88 




Here, we catalogued the mucosal microbiome in different regions of the human 91 
colon, a gastrointestinal organ with the most diverse and dense microbiome content 92 
and region-restricted disease states 14. In parallel, we applied single-cell RNA-seq 93 
(scRNA-seq) to make a census of steady-state immune cell populations in the 94 
adjacent tissue and in draining mesenteric lymph nodes (mLN), available at 95 
www.gutcellatlas.org. We demonstrate previously unappreciated changes in the 96 
proportions and activation status of T and B cells in distinct regions of the healthy 97 
human colon from proximal to distal, and relate these differences to the changing 98 
microbiota. 99 
 100 




Microbiome composition differs along distinct colon regions  103 
To create a map of bacterial composition at the mucosal surface of the colon, we 104 
performed 16S ribosomal sequencing of swabs from the mucosa surface of the 105 
caecum, transverse colon and sigmoid colon of twelve disease-free Caucasian 106 
deceased transplant donors (Figure 1a & Supp Table 1). The major gut phyla - 107 
Bacteroidetes, Firmicutes, Proteobacteria and Actinobacteria, were present 108 
throughout the gut of each donor (Figure 1b & Supp Table 2). While diversity of 109 
OTUs was consistent across the colon, and significant variability existed between 110 
donor as previously reported 15 (Supp Figure 1a), we did observe changes in the 111 
composition of the microbiome. Most notably at the level of phyla, Bacteroidetes was 112 
more prevalent in sigmoid colon (Figure 1c & Supp Figure 1b). This was mostly 113 
attributable to an increase in Bacteroides, which dominates the colonic microbiome 114 
of individuals on high protein and fat diets typical in Western countries 16 (Figure 1c 115 
and Supp Figure 1a). Additionally, Enterococcus was more prevalent in the proximal 116 
colon, and Coprobacillus and Shigella, typically pathogenic, were more abundant in 117 
the distal colon, although these proportions varied considerably between donors 118 
(Figure 1b & 1c & Supp Figure 1c).  119 
 120 
Past studies characterising the colonic microbiome typically rely on stool samples, 121 
which do not accurately recapitulate the composition of bacteria at the mucosal 122 
surface 17. Our catalog of mucosal bacteria throughout the colon demonstrates 123 
heterogeneity in the microbiome at the mucosal surface from proximal to distal colon, 124 




Immune cell heterogeneity in steady-state colon 127 
Next, we sought to determine whether the heterogeneity we observed in the colonic 128 
microbiome was accompanied by differences in the adjacent host immune cells. To 129 
this end, we generated high-quality transcriptional data from over 41,000 single 130 
immune cells from the mLN and lamina propria of caecum, transverse colon and 131 
sigmoid colon (Figure 1a). We acquired tissue biopsies from five deceased 132 
transplant donors (Supp Table 1). Samples were dissociated to release cells from 133 
the mLN and lamina propria of colonic tissue. Immune cells were enriched either by 134 
fluorescence-activated cell sorting (FACS) of CD4+ T cells (live CD45+CD3+CD4+) 135 
and other immune cells (live CD45+CD3-CD4-), or by CD45+ magnetic bead selection 136 
or Ficoll gradient. Each fraction was then subjected to scRNA-seq (see Methods; 137 
Figure 1a & Supp. Figure 1d). Despite the enrichment for immune cells, we captured 138 
epithelial cells and fibroblasts and these were computationally removed from further 139 
analysis (see Methods). 140 
 141 
Pooled analysis and visualisation with Uniform Manifold Approximation and 142 
Projection (UMAP) of all four tissues from all donors revealed distinct clusters in the 143 
lymphoid and colonic tissues (Figure 1d & Supp Figure 1e). We identified 25 cell 144 
types and states in the intestinal lamina propria and mLN (Figure 1d & Supp Table 3 145 
& Supp Table 4), consistent with the immune populations described in recent reports 146 
18. Among these were follicular and memory B cells, IgA+ and IgG+ plasma cells, 147 
effector and memory CD4+ T cells, T regulatory (Treg) cells, CD8+ T cells, γδ T cells, 148 
innate lymphoid cells (ILCs), natural killer (NK) cells, mast cells and myeloid cells 149 
(Figure 1d). Sub-clustering of myeloid cells showed two distinct populations of 150 
conventional dendritic cells: cDC1 expressing XCR1, CADM1, CLEC9A, BATF3 and 151 
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IDO1, and cDC2 expressing CLEC10A and CD86 (Figure 1d & 1e). In addition, we 152 
identified monocytes expressing CD14 and CD68, macrophages expressing 153 
FCGR3A (gene encoding CD16), LYVE1 macrophages 19 and plasmacytoid DCs 154 
(pDCs) expressing IRF4 and SELL. B cells, DCs and γδ T cells had MKI67+ cycling 155 
populations suggesting higher rates of proliferation compared to other colonic 156 
immune cell populations (Figure 1d & 1e). 157 
 158 
To determine how immune cells differ along the colon from proximal to distal regions, 159 
we investigated the relative proportions of cell types within mLN and colon regions 160 
(Figure 1f & 1g). Since CD4+ T cells and all other immune cells were sorted 161 
separately during initial tissue processing, our analyses here were also kept 162 
separate. As noted from our visual inspection of the UMAP plot (Figure 1d), there 163 
were major differences in the cell types present between mLN and the colon. In 164 
particular, there were marked differences in the activation and memory status of T 165 
and B cells between the colon and lymph nodes, suggesting that these cell types are 166 
moulded by their environment (Figure 1f & 1g). In the mLN, CD4+ T cells were 167 
typically CXCR5+, ICOShi follicular helper cells, and SELL+ (encodes CD62L), CCR7+ 168 
central memory cells (Figure 1e and 1f). In contrast, colonic CD4+ T cells had a more 169 
effector phenotype, expressing high levels of the tissue residency marker CD69 20, 170 
falling into the Th17 (CCR6+, IL22+) or Th1 (CXCR3+, IFNG+) subtypes. There was 171 
an inverted gradient in the relative proportion of Th17 and Th1 cells, with the caecum 172 
dominated by Th17 cells that reduced in frequency in the transverse colon, and still 173 
further in the sigmoid colon, and Th1 cells following the opposite trend, being more 174 
abundant in the sigmoid colon (Figure 1f). This distinct distribution of colonic Th1 and 175 
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Th17 cells is concordant with spatial variation of the microbiome, hinting at a 176 
relationship between the two populations.  177 
 178 
B cells in the mLN were predominantly CD19+, MS4A1+ (encodes CD20), CD40+, 179 
TNFRSF13B+ (encodes TACI), CD38- memory or CXCR5+, TCL1A+, FCER2+ 180 
(encodes CD23) follicular B cells (Figure 1e and 1g). In contrast, in the three regions 181 
of the colon, the main population of B cells were SDC1+ (encodes CD138), CD38+, 182 
plasma cells. Curiously, plasma cells were enriched in the sigmoid colon relative to 183 
both the caecum and transverse colon, whilst the proportion of memory B cells was 184 
lower in the sigmoid colon (Figure 1g). This suggests that conditions in the sigmoid 185 
colon may favour the generation of plasma cells rather than memory B cells from 186 
germinal centre responses in this region, or that the tissue contains more plasma cell 187 
niches. 188 
 189 
T helper cells disseminate through the colon and adopt region-specific 190 
transcriptional profiles 191 
We next investigated CD4+ T effector cells across the colon. Correlation analysis of 192 
Th1 and Th17 cells between different colon tissues revealed high transcriptional 193 
similarity between these effector cell subtypes (Figure 2a), with mLN versus 194 
peripheral tissue signature accounting for the greatest amount of variability 195 
(Spearman’s corr = 0.88). Within the effector T cells of the colon, transverse colon 196 
and caecum cells cluster by T helper subtype. Surprisingly, Th1 and Th17 cells of 197 
the sigmoid colon did not cluster with their respective effector subtypes from other 198 
regions. Differential gene expression analysis between the effector cells in the 199 
sigmoid colon versus those in caecum and transverse colon revealed higher 200 
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expression of activation-related molecules including TANK (TRAF family member 201 
associated NF-kB activator) (adjusted P < 10-10), CD83 (adjusted P < 10-10) and 202 
PIM3 (adjusted P < 10-8) (Figure 2b). Expression of CCL20, encoding the ligand for 203 
CCR6 that is expressed by epithelial and myeloid cells more highly in small 204 
intestines than colon 21, was also slightly increased by T helper cells of the proximal 205 
colon (Figure 2b), although this is likely due to higher abundance of CCL20+ Th17 206 
cells at this site (Figure 1f & Supp Figure 2a). Conversely, sigmoid colon effector T 207 
cells showed higher expression of KLF2 (adjusted P < 10-14) (Figure 2b) that 208 
encodes a transcriptional factor that transactivates the promoter for Sphingosine-1-209 
phosphate receptor 1 (S1PR1) and is critical for T cell recirculation through 210 
peripheral lymphoid tissue 22, LMNA (adjusted P < 10-47) that is reported to promote 211 
Th1 differentiation 23 and EEF1G (adjusted P < 10-13), a driver of protein synthesis 24.  212 
 213 
Next, we looked into the clonal relationships between T helper cells. We performed 214 
plate-based Smartseq2 on TCRα/β+ FACS-sorted cells from colon regions and mLN 215 
of a sixth donor to capture paired gene expression and TCR sequences from 216 
individual T cells. Clonal groups were shared between Th1 and Th17 subtypes, 217 
supporting the notion that effector fate of CD4+ T cells is determined after their initial 218 
activation 25. Additionally, clonal expansion was observed by Th1 cells of the sigmoid 219 
colon (Figure 2C), in line with greater abundance in this tissue. Likewise, clonal 220 
expansion of Th17 cells was greatest in the caecum matching accumulation seen 221 
with the droplet-based scRNA-seq analysis. Several Th1 and Th17 clonal sisters 222 
were shared between clonal sites (Figure 2C), evidence that Th clones disseminate 223 




Together these data demonstrate region-specific transcriptional differences relating 226 
to activation and tissue migration in Th1 and Th17 cells of the proximal and sigmoid 227 
colon. Identification of clonal sharing between these colon regions supports the idea 228 
that these observed transcriptional differences are due to cell-extrinsic rather than 229 
intrinsic factors.  230 
 231 
Activation trajectory of colonic CD4+ T regulatory cells 232 
Treg cells are known to play a role in balancing the immune activity of other CD4 T 233 
cell subsets. Documented Treg cell activation by Clostridium spp.10 and previous 234 
descriptions of tissue-specific transcriptional profiles 26 inspired us to interrogate 235 
these cells in greater detail. Firstly, we noted that the relative proportion of Treg cells 236 
did not change significantly from proximal to distal colon (Figure 1f). We then 237 
investigated whether the transcriptional profiles of Tregs from different compartments 238 
indicated distinct activation states or functionalities.  239 
 240 
As we previously observed in the mouse 26, sub-clustering of Treg cells from the 241 
mLN revealed major populations of central Tregs and effector Tregs (Figure 3a)26. 242 
Central Tregs were defined by highest expression of SELL, while effector Tregs were 243 
characterised by genes associated with the TNFRSF-NF-κB pathway (TNFRSF9 and 244 
TNF) (Supp Figure 3a). In addition, we observed a population, previously termed 245 
non-lymphoid tissue-like Tregs (NLT-like Treg). These have characteristics of non-246 
lymphoid tissue Treg cells, including high expression of FOXP3, PRDM1, RORA, 247 
IL2RG, IL2RA and CTLA4 (Figure 3a & Supp Figure 3a). A fourth population, termed 248 
Treg-like cells, lacked the conventional markers of Treg cells - FOXP3 and IL2RA - 249 
but clustered more closely with Treg cells than conventional T cells (Figure 3a and 250 
 
12 
Supp Figure 3a). These expressed the highest levels of PDCD1 (gene encoding PD-251 
1) among Treg populations and, uniquely, the transmembrane protein MS4A6A 252 
(Supp Figure 3a). This population of Treg-like cells could represent a Treg 253 
population that transiently loses FOXP3 expression 27.  254 
 255 
In the colon, Tregs clustered into three populations as previously described in mouse 256 
(Figure 3a) 26. KLRB1+ (also known as CD161) Treg cells were characterised by 257 
expression of LAG3, IL2RA, CTLA4, KLRB1, ICOS and FOXP3 (Supp Figure 3a) 258 
suggesting a robust regulatory function, analogous to the peripherally-derived 259 
induced Treg cells described in mouse 28 and similar to CD161+ Tregs described in 260 
human colon tissue 20,29. Non-lymphoid tissue Treg (NLT Treg) cells express IKZF2, 261 
GATA3 and DUSP4 (Supp Figure 3a) consistent with the profile of thymic-derived 262 
Tregs 30. The third population exhibited a profile reminiscent of lymphoid tissue Tregs 263 
with expression of SELL, CCR7, TCR7, CXCR5 and RGS2, and were termed 264 
Lymphoid Tissue-like Treg (LT-like Treg) cells (Supp Figure 3a). LT-like Treg cells 265 
are likely newly arrived in the colon tissue from mLN. A small number of Ki67+ Treg 266 
cells were also identified in the colon and mLN (Figure 3a & Supp Table 3). The 267 
proportions of these subsets varied by donor, but were mostly consistent between 268 
colon regions (Figure 3b). 269 
 270 
The presence of NLT-like Treg cells in the mLN and LT-like Treg cells in the colon, 271 
both with profiles suggesting migration, led us to recreate this migration pathway in 272 
silico. We ordered all Tregs along “pseudo-space” using Monocle2. This gave rise to 273 
a smooth pseudo-space trajectory from resting central Tregs in the mLN to highly 274 
suppressive Tregs in the colon (Figure 3c). As seen in the mouse 26, NLT-like Tregs 275 
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and LT-like Tregs blended in the middle of the trajectory, in accordance with these 276 
cells representing transitioning and migratory populations between lymphoid and 277 
peripheral tissues. In order to understand which gene signatures drive the migration 278 
and tissue adaptation of Tregs in human tissues, we determined the genes changing 279 
along the previously calculated ‘pseudo-space’ (Figure 3c). Genes expressed at the 280 
beginning of pseudo-space included SELL, CCR7 and CXCR4, permitting entry into 281 
lymph nodes (Figure 3c). At the end of pseudo-space, the most highly expressed 282 
genes were FOXP3, IL2RA, CTLA4, IL10 and LAG3. These largely suppressive 283 
genes were co-expressed with TNF receptors (TNFRSF4, TNFRSF14, TNFRSF18, 284 
TNFRSF1B) indicating a reliance on the TNFRSF-NF-κB axis. Chemokine receptors 285 
CXCR3, CXCR6, CCR6 and CCR4 were also expressed by Tregs cells in the 286 
periphery, matching previous reports of Th1/Th17-like Tregs cells in the colon 287 
(Figure 3c)26.  288 
 289 
Together, these results highlight heterogeneity in Treg cell states in mLN and colon, 290 
and reveal a possible Foxp3-transiently absent population. We also infer a 291 
continuous activation trajectory of these Treg cell states between draining lymph 292 
nodes and colon, and highlight genes regulating Treg cell migration between tissues 293 
and their adoption of Th-like profiles.  294 
 295 
B cells display a proximal-to-distal activation gradient 296 
Following from our observations in CD4+ T cells across the colon, we next focused 297 
on humoral responses by performing a more in-depth analysis of B cells in different 298 
colon regions. We compared transcriptional profiles of plasma cells between different 299 
colonic regions. This analysis revealed CCL3 and CCL4 as highly enriched in caecal 300 
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plasma cells (log fold change of 0.61 and 0.70 and adjusted P <10-28 and <10-9 301 
respectively) (Figure 4a). These chemokines are secreted by B cells in response to 302 
BCR activation 31 and result in the migration of CCR5-expressing cells such as T 303 
cells 32,33 and monocytes 34 to the tissue microenvironment. This suggests that BCR 304 
cross-linking and signalling may be more prominent in the proximal colon. Caecal 305 
plasma B cells were also enriched for CXCR4 (log fold change of 0.44, adjusted P < 306 
10-10) (Figure 4a), a chemokine receptor highly expressed by germinal centre (GC) B 307 
cells and important for the movement of plasmablasts to the GC-T zone interface 308 
post-GC responses 35.  309 
 310 
Amongst the genes more highly expressed by plasma cells in the sigmoid colon was 311 
CD27 (Figure 4a; log fold change of 0.24; adjusted P <10-40), a member of the TNF 312 
receptor family that is expressed by memory B cells and even more highly by plasma 313 
cells 36. We confirmed differential expression of CD27 at the protein level and 314 
additionally observed a proximal-to-distal gradient of increasing CD27 expression by 315 
plasma cells in the colon (Figure 4b). Targeted homing of B cells from their site of 316 
activation in lymphoid tissues to the colonic lamina propria relies on signalling 317 
through CCR10 and its cognate ligand, CCL28, and integrin α4β7 37,38,39. CCR10 (log 318 
fold change of 0.24; adjusted P < 10-16), ITGA4 (log fold change of 0.58; adjusted P 319 
< 10-24) and ITGB4 (log fold change 0.57; adjusted P < 10-108) were also more highly 320 
expressed by sigmoid colon IgA+ plasma cells (Figure 4a). 321 
 322 
To determine whether the B cell clonal repertoire changes across the colon, we took 323 
advantage of the paired single-cell VDJ-sequencing data available from two donors 324 
for which scRNA-seq libraries were generated using 10x Genomics 5’ chemistry. We 325 
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confirmed the expression of IgM and IgD isotypes by follicular B cells, IgG1 and IgG2 326 
by IgG+ plasma cells, IgA1 and IgM expression by memory cells in the mLN and 327 
predominantly IgA2 expression by plasma cells of the colon (Figure 4c). The 328 
mutation frequency of the heavy chain variable region was greatest in the plasma 329 
cells followed by memory B cells, indicating more somatic hypermutation by these 330 
cell types compared to the naive follicular B cells (Figure 4d). Additionally, while 331 
mutational frequency was consistent across colon regions and mLN for memory and 332 
follicular B cells, it was significantly increased in IgA+ plasma cell of the sigmoid 333 
colon compared to the other colon regions (Figure 4e). IgG+ plasma cells also 334 
showed a trend towards increased mutational frequency in the sigmoid colon, 335 
however their numbers were limiting (Figure 4e).  336 
 337 
We then identified clonally-related B cells and plasma cells examine clonal 338 
expansion dynamics of different cellular populations throughout the gut. Clonal 339 
expansion was evident in memory B cells, IgA+ plasma cells and IgG+ plasma cells 340 
(Figure 4f). While the relative abundance of clonal groups did not differ across the 341 
colon regions of memory B cells and IgG+ plasma cells, again this was greatest for 342 
IgA+ plasma cells in the sigmoid colon (Figure 4f). This was supported by 343 
bootstrapped VDJ sequence diversity analysis of clonally-related IgA+ plasma cells, 344 
which showed that the diversity of BCR sequences was consistent between donors 345 
and that there was a trend for decreased diversity (consistent with higher rates of 346 
clonal expansion) of IgA+ plasma cells in the sigmoid colon (Supp Figure 4a & 4b). 347 
While some clones were shared between B cell types (i.e. memory and IgA+ 348 
plasma), indicating that alternate B cell fates can derive from a single precursor cell, 349 
most expanded clones within the gut were of the same cell type (Supp Figure 4c). 350 
 
16 
Finally, we found many examples of B cell clones shared between all three colonic 351 
regions, and to a lesser extent the mLN, for both donors (Figure 4g), indicating 352 
dissemination of B cells throughout the colon as previously reported 40. Our 353 
observation of B cell dissemination throughout the colon was replicated with bulk 354 
BCR sequencing from whole tissue (Figure 4h) 41. Interestingly, increased clonal 355 
variability of sigmoid colon B cells was reflected in a greater spread of BCR variable 356 
chains expressed compared with caecum and transverse colon (Supp. Figure 4d), 357 
altogether suggesting a more active response in the distal versus proximal colon.  358 
 359 
These data indicate a highly activated state of plasma cells in the distal colon 360 
compared with proximal colon plasma cells, characterised by greater accumulation, 361 
somatic hypermutation, clonal expansion and stronger homing to the colon mucosa.  362 
 363 
IgA is more responsive to specific bacterial species in the sigmoid colon 364 
Reports by Macpherson et al. have shown that IgA is secreted by plasma cells in 365 
response to the presence of specific bacteria species, rather than as a general 366 
response to the microbiome 42. In light of this, we wondered whether the increased 367 
plasma cell activation we observed in the sigmoid colon was linked to the differences 368 
in reactive bacteria species. To this end, we assessed IgA-opsonisation of bacteria 369 
from the donor microbiome samples (Figure 5a). Surprisingly, a greater proportion of 370 
bacteria from the sigmoid colon was positive for IgA-binding compared with bacteria 371 
of the caecum and transverse colon (Figure 5b). Furthermore, shotgun sequencing 372 
of IgA-opsonised bacteria revealed a richer community of species in the sigmoid 373 
colon (Figure 5c & Supp Table 5). Interestingly, diversity of IgA-bound bacteria, 374 
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which considers relative abundance of each species, was lower in the sigmoid colon 375 
compared to caecum (Figure 5d).  376 
 377 
These data suggest that, compared with the caecum, IgA+ plasma cells of the 378 
sigmoid colon respond to a rich and unevenly represented community of bacterial 379 
species, likely contributing to their increased activation status, strong homing to the 380 
colon and trend towards greater clonal diversity (Figure 5e).  381 
 382 




In this study we performed the first simultaneous assessment of the colonic mucosal 385 
microbiome and immune cells in human donors at steady-state. This enabled us to 386 
compare lymphoid and peripheral tissue immunity and explore how immune cells 387 
and their neighbouring microbiome change along the colon within the same 388 
individuals. In doing so, we highlight previously unappreciated regional differences in 389 
both cellular communities. Our unique annotated colon immune single-cell dataset is 390 
available at www.gutcellatlas.org, where users can visualise their genes of interest. 391 
 392 
We describe a shift in the balance of T helper subsets, with a predominance of Th17 393 
in the caecum and Th1 in the sigmoid colon. Decreasing abundance of Th17 cells 394 
has similarly been shown from proximal small intestine to colon of mice 7. 395 
Additionally, simultaneous increase of the genus Bacteroides and Th1 numbers in 396 
the sigmoid colon are in line with findings that polysaccharide from Bacteroides 397 
fragilis preferentially induces Th1 differentiation in the intestine of germ-free mice 11. 398 
An alternative or complementary explanation for skewed T helper proportions and 399 
variation in transcriptional profiles is offered in a study by Harbour et al., which 400 
demonstrated that Th17 cells can give rise to a IFNy+ ‘Th1-like’ cell in response to IL-401 
23 production by innate cells 43. These findings demonstrate the complexity of 402 
external signals shaping colonic Th responses leading to regional changes in their 403 
numbers and differentiation.  404 
 405 
In contrast to conventional T cells, Treg cells are evenly represented across the 406 
colon. Treg cell subpopulations within the mLN and colon tissue are analogous to 407 
those we have recently described in mouse 26. We also identify an additional 408 
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population, termed Treg-like cells, reminiscent of a CD25-FOXP3loPD1hi Treg 409 
population in the peripheral blood, although the latter was described to also express 410 
Ki67 44. This population could represent uncommitted Treg cells experiencing 411 
transient loss of FOXP3 while retaining regulatory potential 27 or permanent loss 412 
FOXP3 and adoption of a more pro-inflammatory phenotype after repeated 413 
stimulation 45. Our pseudo-space analysis of Treg cells suggests a continuum of 414 
activation states from resting cells in the lymphoid tissue through to highly 415 
suppressive cells in the periphery. We identify genes underlying this transition 416 
including chemokine receptors that are strongly expressed on arrival in the intestine 417 
that enable interaction with, and suppression of, Th1 and Th17 cells 46. Similarly to 418 
mouse, pseudospace from lymphoid to peripheral tissue correlates with 419 
transcriptional markers of migratory potential and suppression of effector cells. 420 
 421 
We find that IgA+ plasma cells are more abundant and have greater expression of 422 
colon-specific migration markers (CCR10, ITGA4 and ITGB7) in the sigmoid colon 423 
compared to the proximal colon. This adds finer resolution to previous reports 424 
describing increasing abundance of IgA+ plasma cells from the small intestine to the 425 
colon 47. Our B cell repertoire analysis demonstrates extensive clonal expansion 426 
within each colon region and to a lesser extent between regions, arguing for colonic 427 
dissemination of B cells from the same precursor pool, followed by local expansion. 428 
Furthermore, more clonal sharing existed between regions of the colon than with 429 
mLN, consistent with recent work showing that while mLN clones can also be 430 
detected in blood, the intestines are host to a unique B cell clonal network 48. 431 
Sigmoid colon plasma cells, in particular, exhibit greater mutational abundance and 432 
clonal expansion. Previous work has shown the mutational frequency of B cells is 433 
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consistently high between duodenum and colon and are primarily driven by dietary 434 
and microbiome antigens respectively 49. Thus, we suggest that enhanced plasma 435 
cell accumulation, mutation and expansion in the sigmoid colon is in response to 436 
continued stimulation from the local microbiome. This may happen through 437 
increased engagement of sigmoid colon plasma cells in T cell-mediated germinal 438 
centre reactions in gut-associated lymphoid structures or in T cell-independent 439 
somatic hypermutation in local isolated lymphoid follicles 50 followed by local 440 
expansion. Yet the exact mechanisms require further study.  441 
 442 
Finally, we show greater IgA binding to the microbiome in the sigmoid colon 443 
compared to proximal sites (Figure 5b). One possible explanation for this 444 
observation is the accumulation of upstream secreted IgA and IgA-bound bacteria in 445 
the sigmoid colon. However, our simultaneous observation of enhanced plasma cell 446 
responses in the sigmoid colon suggests that IgA is locally produced as a result of 447 
immune poising. Possible scenarios contributing to a richer immune-reactive 448 
microbiome in the sigmoid colon are bacteria derived externally via the rectum. 449 
Alternatively, environmental pressures (i.e. lower water and nutrient levels 4) could 450 
restrict outgrowth of dominant gastrointestinal species of the proximal colon, 451 
providing space for smaller communities of opportunistic species. The IgA response 452 
in the colon is antigen-specific rather than a general response to the presence of 453 
bacteria 51,42. Thus, the overall increased number of unique species recognised by 454 
host IgA antibodies in the sigmoid colon is fitting with the enhanced clonal expansion 455 




Together, our simultaneous analyses of microbiome and neighbouring immune cells 458 
highlight the significance of environmental signals in shaping and maintaining 459 
regional adaptive immune cell composition and function in the intestine at steady-460 
state. Dysregulation of T helper cells 52 and plasma cells 53,54,55 has been implicated 461 
in susceptibility to inflammatory bowel disease. Observations of the linked 462 
compartmentalisation of these immune cells and microbial species along the colon at 463 
steady-state may provide a platform for understanding the mechanisms underpinning 464 
the tropism of different intestinal diseases to specific regions of the gut, such as 465 
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Colon and mesenteric lymph node tissue retrieval 508 
Human tissue was obtained from deceased transplant organ donors after ethical 509 
approval (reference 15/EE/0152, East of England Cambridge South Research Ethics 510 
Committee) and informed consent from the donor family. Fresh mucosal tissue from 511 
the caecum, transverse colon and sigmoid colon, and lymph nodes from the intestine 512 
mesentery, were excised within 60 minutes of circulatory arrest and colon tissue 513 
preserved in University of Wisconsin (UW) organ preservation solution (Belzer UW® 514 
Cold Storage Solution, Bridge to Life, USA) and mLN stored in saline at 4°C until 515 
processing. Tissue dissociation was conducted within 2 hours of tissue retrieval. 516 
Four individuals (287c, 296b, 403c and 411c) had received antibiotics in the two 517 
weeks prior to death (Supp. Table 1). 518 
 519 
Tissue dissociation for FACS separation and MAC separation  520 
Tissue pieces from donors 290b, 298c, 302c, 364b and 411c were manually diced 521 
and transferred into 5mM EDTA (Thermo Fisher Scientific)/1mM DTT/10mM HEPES 522 
(Thermo Fisher Scientific)/2% FBS in RPMI and incubated in a shaker (~200rpm) for 523 
20 minutes at 37oC. Samples were briefly vortexed before the media renewed and 524 
incubation repeated. Tissue pieces were washed with 10mM HEPES in PBS and 525 
transferred into 0.42mg/ml Liberase DT (Roche)/0.125 KU DNase1 (Sigma)/10mM 526 
HEPES in RPMI and incubation for 30 minutes at 37oC. The digested samples were 527 
passed through a 40um strainer and washed through with FBS/PBS.  528 
 529 
Fluorescence-activated cell sorting 530 
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Cells from donor 290b, 298c and 302c were pelleted and resuspended in 40% 531 
Percoll (GE Healthcare). This was underlayed with 80% Percoll and centrifuged at 532 
600g for 20 minutes with minimal acceleration and break. Cells at the interface were 533 
collected and washed with PBS. Cells were stained for fluorescent cytometry using 534 
Zombie Aqua Fixable Viability Dye (Biolegend), CD45-BV605 (clone HI30; 535 
Biolegend), CD3-FITC (clone OKT3; Biolegend), CD4-BV421 (clone SK3; 536 
Biolegend), CD8-PE-Cy7 (clone SK1; Biolegend), CD19-APC-Cy7 (clone HIB19; 537 
Biolegend), IgD-PE Dazzle (clone IA6-2; Biolegend), CD27-BV711 (clone M-T271; 538 
Biolegend), HLA-DR- BV785 (clone L243; Biolegend), CD14-APC (clone 63D3; 539 
Biolegend) and CD11c-PE (clone 3.9; eBioscience). Non-CD4+ T immune cells were 540 
sorted as live singlet CD45+, CD3- and CD4-. CD4+ T cells were sorted as live singlet 541 
CD45+, CD3+ and CD4+. Each faction was manually counted using 0.4% Trypan 542 
Blue (gibco) and a haemocytometer and diluted to 500 cells/ul in PBS. Sorting was 543 
carried out on a BD FACS ARIA Fusion. Analysis of FACS data was conducted with 544 
FlowJo Software package.  545 
 546 
MACS cell enrichment 547 
Cells from donor 411c were pelleted for 5mins at 300g and resuspended in 80ul of 548 
ice-cold MACS buffer (0.5% BSA (Sigma-Aldrich Co. Ltd), 2mM EDTA 549 
(ThermoFisher) in DPBS (Gibco)) and 20ul of CD45 Microbeads (Miltenyi Biotech). 550 
Cells were incubated for 15 minutes at 4oC before being washed with 2ml of MACS 551 
buffer and centrifuged as above. Cells were resuspended in 500ul of MACS buffer 552 
and passed through a pre-wetted MS column on QuadroMACS magnetic cell 553 
separator (Miltenyi). The column was washed 4 times with 500ul of MACS buffer, 554 
allowing the full volume of each wash to pass through the column before the next 555 
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wash. The column was removed from the magnet and the cells eluted with force with 556 
1ml of MACS buffer into a 15ml tube. Cells were pelleted as above and cell number 557 
and viability were determined using a NucleoCounter NC-200 and Via1-Cassette 558 
(ChemoMetec). Cells were resuspended at 500 cells/ul in 0.04% BSA in PBS. 559 
 560 
Tissue dissociation for Ficoll separation 561 
Tissues from donor 390c were manually diced and <5.0g was added per Miltenyi C 562 
tube with 5mL tissue dissociation media (1x Liberase TL (0.13U/mL/DNase; Roche) 563 
and Benzonase nuclease (10U/mL; Merck) in 1% FCS and 20mM HEPES in PBS 564 
(Lonza). Samples were dissociated with GentleMACS Octo for 30 minutes 565 
homogenising/37oC cycle. Enzymatic digestion was stopped with the addition of 566 
2mM EDTA in tissue dissociation media. Digested samples were then passed 567 
through a 70uM smart strainer (Miltenyi) before being washed with PBS and pelleted 568 
at 500g for 10 minutes. Cells were resuspended in PBS, layered onto FicollPaque 569 
Plus (GE Healthcare) and spun at RT 400g for 25 minutes. Mononuclear cells were 570 
retrieved from Ficoll layer and washed with PBS. Cells were filtered through 0.2uM 571 
filter (FLowmi cell strainers, BelArt). Cells were manually counted using a 572 
haemocytometer and diluted to a concentration of 1000 cells/µl in 0.04% BSA in 573 
PBS.  574 
 575 
10x Genomics Chromium GEX library preparation and sequencing 576 
Cells were loaded according to the manufacturer’s protocol for Chromium single cell 577 
3’ kit (version 2) or 5’ gene expression (version 2) in order to attain between 2000-578 
5000 cells/well. Library preparation was carried out according to the manufacturer’s 579 
protocol. For samples from donors 290b, 298c and 302c, eight 10x Genomics 580 
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Chromium 3’ libraries were pooled sequenced on eight lanes of an Illumina Hiseq 581 
4000. For samples from donors 390c and 417c, sixteen 10x Genomics Chromium 5’ 582 
libraries were pooled and sequenced on 2 lanes of a S2 flowcell of Illumina Novaseq 583 
with 50bp paired end reads.  584 
 585 
10x Genomics Chromium VDJ library preparation and sequencing 586 
10x Genomics VDJ libraries were generated from the 5’ 10x Genomics Chromium 587 
cDNA libraries as detailed in the manufacturer's protocol. BCR libraries for each 588 
sample were pooled and sequenced on a single lane of Illumina HiSeq 4000 with 589 
150bp paired end reads. 590 
 591 
Plate-based scRNA-seq 592 
Plate based scRNA-seq was performed with the NEBNext Single Cell/Low Input 593 
RNA Library Prep Kit for Illumina (New England Biolabs Inc, E6420L). Cells from 594 
donor 364b were snap frozen in 10% DMSO in 90% BSA. Cells were thawed rapidly 595 
in a 37oC water bath and diluted slowly with pre-warmed 2% FBS in D-PBS. Cells 596 
were pelleted for 5 minutes at 300g and washed with 500ul of DPBS and pelleted as 597 
before. Cells were resuspended in 200ul of CD25-PE (clone M-A251, Biolegend), 598 
CD127-FITC (clone EBIORDR5, eBioscience), CD4-BV421 (clone SK3, Biolegend) 599 
and TCRα/β-APC (clone 1p26, Biolegend) (all diluted 1:200) and Zombie Aqua 600 
Fixable Viability Dye (Biolegend) (diluted 1:1000) and incubated for 30 minutes in the 601 
dark at room temperature. Cells were washed twice with 500ul of 2% FBS in D-PBS 602 
before being filtered through a 100uM filter. Single, live, TCRβ+ cells were FACS 603 
sorted into a pre-prepared 384-well plate (Eppendorf, Cat. No. 0030128508) 604 
containing 2 µl of 1X NEBNext Cell Lysis Buffer. FACS sorting was performed with a 605 
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BD Influx sorter with the indexing setting enabled. Plates were sealed and spun at 606 
100 x g for 1 minute then immediately frozen on dry ice and stored at -80 °C.  607 
 608 
cDNA generation was then performed in an automated manner on the Agilent Bravo 609 
NGS workstation (Agilent Technologies). Briefly, 1.6 µl of Single Cell RT Primer Mix 610 
was added to each well and annealed on a PCR machine (MJ Research Peltier 611 
Thermal Cycler) at 70°C for 5 minutes. 4.4 µl of Reverse Transcription (RT) mix was 612 
added to the mixture and further incubated at 42°C for 90 minutes followed by 70°C 613 
for 10 minutes to generate cDNA. 22 µl of cDNA amplification mix containing 614 
NEBNext Single Cell cDNA PCR MasterMix and PCR primer was mixed with the 615 
cDNA, sealed and spun at 100 x g for 1 minute. cDNA amplification was then 616 
performed on a PCR machine (MJ Research Peltier Thermal Cycler) with 98°C 45 s, 617 
20 cycles of [98°C 10 s, 62°C 15 s, 72°C 3 mins], 72°C 5 mins. The 384-well plate 618 
containing the amplified cDNA was purified with an AMPure XP workflow (Beckman 619 
Coulter, Cat No. A63880) and quantified with the Accuclear Ultra High Sensitivity 620 
dsDNA kit (Biotium, Cat. No. 31028). ~10 ng of cDNA was stamped into a fresh 384-621 
well plate (Eppendorf, Cat. No. 0030128508) for sequencing library preparation. 622 
 623 
Sequencing libraries were then generated on the Agilent Bravo NGS workstation 624 
(Agilent Technologies). Purified cDNA was fragmented by the addition of 0.8 µl of 625 
NEBNext Ultra II FS Enzyme Mix and 2.8 µl of NEBNext Ultra II FS Reaction buffer 626 
to each well and incubated on a PCR machine (MJ Research Peltier Thermal Cycler) 627 
for 72°C at 15 minutes and 65°C for 30 minutes. A ligation mixture was then 628 
prepared containing NEBNext Ultra II Ligation Master Mix, NEBNext Ligation 629 
Enhancer and 100 µM Illumina compatible adapters (Integrated DNA Technologies) 630 
 
29 
and 13.4 µl added to each well of the 384-well plate. The ligation reaction was 631 
incubated on the Agilent workstation at 20°C for 15 minutes and then purified and 632 
size selected with an AMPure XP workflow (Beckman Coulter, Cat No. A63880). 20 633 
µl of KAPA HiFi HS Ready Mix (Kapa Biosystems, Cat. No. 07958927001) was then 634 
added to a pre-prepared 384-well plate (Eppendorf, Cat. No. 0030128508) 635 
containing 100 µM i5 and i7 indexing primer mix (50 µM each) (Integrated DNA 636 
Technologies). The indexing primers pairs were unique to allow multiplexing of up to 637 
384 single cells in one sequencing pool. The plate containing the PCR Master Mix 638 
and indexing primers was stamped onto the adapter ligated purified cDNA, sealed 639 
and spun at 100 x g for 1 minute. Amplification was performed on a PCR machine 640 
(MJ Research Peltier Thermal Cycler) with 95°C for 5 minutes, 8 cycles of [98°C 30 641 
seconds, 65°C 30 seconds, 72°C 1 minute], 72°C 5 minutes. The PCR products 642 
were pooled in equal volume on the Microlab STAR automated liquid handler 643 
(Hamilton Robotics) and the pool purified and size selected with an AMPure XP 644 
workflow (Beckman Coulter, Cat No. A63880). The purified pool was quantified on 645 
an Agilent Bioanalyser (Agilent Technologies) and sequenced on one lane of an 646 
Illumina HiSeq 4000 instrument. 647 
 648 
Single-cell RNA sequencing data alignment 649 
10x Genomics gene expression raw sequencing data was processed using 650 
CellRanger software version 3.0.2 and 10X human genome GRCh38-3.0.0 as the 651 
reference. 10x Genomics VDJ immunoglobulin heavy and light chain were 652 
processed using cellranger vdj (version 3.1.0) and the reference cellranger-vdj-653 
GRCh38-alts-ensembl-3.1.0 with default settings. NEB sequencing data was 654 
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processed using STAR 2.5.1b into HTSeq and mapped to 10X human genome 655 
GRCh38-1.2.0.  656 
 657 
Single-cell RNA sequencing quality control 658 
Single cell read counts from all samples were pooled and filtered considering 659 
number of UMIs - keeping genes expressed in minimum of 3 cells, keeping cells 660 
where genes detected are in a range 700-6000. Non-immune cells were excluded 661 
from the final analysis based on the absence of PTPRC and presence of markers 662 
such as EPCAM (epithelial cells) and COL1A1 (fibroblasts). 663 
 664 
Cell type annotation 665 
Cells were clustered using Scanpy (version 1.4) processing pipeline 56. In short, the 666 
counts were normalised to 10,000 reads per cell (sc.pp.normalise_per_cell) and log 667 
transformed (sc.pp.log1p) to be comparable amongst the cells. The number of UMIs 668 
and percentage of mitochondrial genes were regressed out (sc.pp.regress_out) and 669 
genes were scaled (sc.pp.scale) to unit variance. The normalised counts were used 670 
to detect highly variable genes (sc.pp.highly_variable_genes). Batch correction 671 
between the donors was performed using bbknn method 57 on 50 PCs and trim 672 
parameter set to 100. Clusters were then identified using Leiden graph-based 673 
clustering (resolution set to 1). Cell identity was assigned using known markers 674 
shown in Figure 1E and the top differentially expressed genes identified using 675 
Wilcoxon rank-sum test (sc.tl.rank_genes_groups function, Supplementary Table 4). 676 
CD4 T cells, myeloid cells, B cells were subclustered for identification of subsets 677 
within each cluster. Treg cells annotated above were further subclustered using the 678 
“FindClusters” and “RunUMAP” functions from Seurat (Version 3.0.1)58 (Figure 3).  679 
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The number of PCs used for Treg cell clustering were estimated by the elbow of a 680 
PCA screen plot, in combination to manual exploration of the top genes from each 681 
PC. Clustering of mLN Treg cells was performed using 1-14 PCs and resolution of 682 
0.3 and colonic Treg cells with 1-11 PCs and resolution of 0.3.  683 
‘Pseudospace’ analysis 684 
‘Pseudospace’ analysis of Treg cells was performed using Monocle 2.2.0 59. Data 685 
was log normalised and cell ordered based on DDRTree reduction on highly variable 686 
genes with donor effect regression. The heatmap in Figure 3c was generated using 687 
the “plot_pseudotime_heatmap” function in Monocle 2.2.0 59. Genes contributing to 688 
‘pseudospace’ were first filtered for exclusion of mitochondria and immunoglobulin 689 
genes, expression in at least 15 cells and qval < 0.001. Gene expression was 690 
smoothed into 100 bins along pseudospace using a natural spline with 3 degrees of 691 
freedom. Matching column annotation for each bin was determined as the most 692 
prevalent tissue region origin of the cells within that bin. Genes were grouped into 2 693 
clusters and ordered by hierarchical clustering. Cells were ordered through 694 
pseudotime. 695 
 696 
Sampling of microbiome 697 
Swabs were taken immediate of the mucosal surface of excised tissue using MWE 698 
Transwab Cary Blair (catalogue number: MW168). Swabs were maintained at 4oC. 699 
Working in a biosafety cabinet, swabs were washed in 500µl of anaerobic PBS and 700 
mixed with anaerobic 50% glycerol before being snap frozen on dry ice and stored at 701 
-80oC until use.  702 
Microbiota profiling and sequencing 703 
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The microbiota vials were defrosted on ice. Approximately 100µl of each was 704 
transferred into new Eppendorf tubes. DNA was extracted from microbiome samples 705 
using the MP Biomedical FastDNA SPIN Kit for soil (catalogue number 116560200). 706 
16S rRNA gene amplicon libraries were made by PCR amplification of variable 707 
regions 1 and 2 of the 16S rRNA gene using the Q5 High-Fidelity Polymerase Kit 708 
supplied by New England Biolabs as described in 60. Primers 27F 709 
AATGATACGGCGACCACCGAGATCTACAC (first part, Illumina adaptor) 710 
TATGGTAATT (second part, forward primer pad) CC (third part, forward primer 711 
linker) AGMGTTYGATYMTGGCTCAG (fourth part, forward primer) and 338R 712 
CAAGCAGAAGACGGCATACGAGAT (first part, reverse complement of 3′ Illumina 713 
adaptor) ACGAGACTGATT (second part, golay barcode) AGTCAGTCAG (third part, 714 
reverse primer pad) AA (fourth part, reverse primer linker) 715 
GCTGCCTCCCGTAGGAGT (fifth part, reverse primer) were used. Four PCR 716 
amplification reactions per sample were carried out; products were pooled and 717 
combined in equimolar amounts for sequencing using the Illumina MiSeq platform, 718 
generating 150bp reads. Analysis of partial 16S rRNA sequences was carried out 719 
using SILVA v132 and mothur MiSeq SOP61. The 16S rRNA gene alignments were 720 
used to determine a maximum likelihood phylogeny using Fasttree 62. Phylogenetic 721 
trees were visualised and edited using iTOL63. 722 
 723 
T cell clonal sharing analysis 724 
T cell receptor sequences generated using the Smartseq2 scRNA-seq protocol were 725 
reconstructed using the TraCeR software as previously described 64. 726 
  727 
Bulk B cell receptor sequencing  728 
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Small portions of samples were taken from excised tissues and snap frozen in 1ml of 729 
RNAlater (Ambion). RNA extracted from tissue using the QIAshreddar and QIAGEN 730 
Mini Kit (50). RNA concentration was measured using a Bioanalyser. B Cell 731 
Receptor (BCR) heavy chain sequences of all B lineage subsets present in the 732 
tissue were amplified as previously described 41. Briefly, RNA was reverse 733 
transcribed using a barcoded reverse primer set capturing all antibody (sub)classes. 734 
Targeted heavy-chain amplification was performed with a multiplex set of IGHV gene 735 
primers to FR1 and a universal reverse primer using HiFI qPCR KAPA Biosystems. 736 
After adapter filtering and trimming, BCR sequences were assembled and aligned 737 
using MiXCR (version 65)65. It is worth noting that detected BCR sequences are 738 
biased towards those included in the reference database and while there is a 739 
continuous discovery of novel germline alleles, no database is currently a complete 740 
reflection of the human IGH locus diversity. Only in-frame and IGH sequences with 741 
at least 3 read counts were kept for the analysis. To calculate the CDR3 nucleotide 742 
shared repertoire, the tcR package was used 66. 743 
 744 
10x Genomics single-cell VDJ data processing, quality control and annotation 745 
Poor quality VDJ contigs that either did not map to immunoglobulin chains or were 746 
assigned incomplete by cellranger were discarded. For additional processing, all IgH 747 
sequence contigs per donor were combined together. We further filtered IgH contigs 748 
as to whether they had sufficient coverage of constant regions to ensure accurate 749 
isotype assignment between closely related subclasses using MaskPrimers.py 750 
(pRESTO version 0.5.10) 67. IgH sequences were then further annotated using 751 
IgBlast 68 and reassigned isotype classes using AssignGenes.py (pRESTO) prior to 752 
correction of ambiguous V gene assignments using TIgGER (version .03.1) 69. 753 
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Clonally-related IgH sequences were identified using DefineClones.py (ChangeO 754 
version 0.4.5) 69 with a nearest neighbour distance threshold of 0.2, as determined 755 
by visual inspection of the output of distToNearest (Shazam version 0.1.11) 69. 756 
CreateGermlines.py (ChangeO version 0.4.5) was then used to infer germline 757 
sequences for each clonal family and observedMutations (Shazam version 0.1.11) 758 
was used to calculate somatic hypermutation frequencies for each IgH contig. 759 
Estimated clonal abundances and IgH diversity analyses within each donor were 760 
performed using estimateAbundance, rarefyDiversity and testDiversity of Alakazam 761 
(version 0.2.11) 69 with a bootstrap number of 500. Finally, the number of quality 762 
filtered and annotated IgH, IgK or IgL were determined per unique cell barcode. If 763 
more than one contig per chain was identified, metadata for that cell was ascribed as 764 
“Multi”. The subsequent metadata table was then integrated with the single-cell RNA-765 
seq gene expression objects for annotation of IgH contigs with B cell types and 766 
downstream analysis. Co-occurence of expanded clone members between tissues 767 
and/or cell types was reported as a binary event for each clone that contained a 768 
member within two different tissues and/or cell types. 769 
 770 
Quantifying IgA binding of bacteria 771 
Microbiome frozen in 50% glycerol were defrosted on ice before being washed in 772 
PBS and pelleted for 3 minutes at 8,000 rpm. Bacteria were then stained on ice for 773 
30 minutes with IgG-PE (Biolegend, clone HP6017), IgA1/2 biotin (BD, clone G20-774 
359), followed by 20 minutes with streptavidin-APC (Biolegend). For isotype controls, 775 
mouse IgG1 κ Isotype- Biotin (BD) or mouse IgG2a, κ Isotype- PE (Biolegend) were 776 
used. The bacteria were washed before and after DNA was stained with 777 
Hoechst33342 (Sigma-Aldrich). The stained bacteria were sorted as Hoechst+ and 778 
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IgG+IgA+ or IgG-IgA+ into PBS using the BD Influx and then stored at -80oC until DNA 779 
extraction. 780 
 781 
Genomic DNA Extraction for shotgun sequencing of IgA-bound bacteria 782 
Bacteria in PBS was defrosted on ice before being pelleted at 3900 rpm for 5 783 
minutes at 4oC. The supernatant was removed and the pellet resuspended in 2ml of 784 
25% sucrose in TE Buffer (10mM Tris pH8 and 1mM EDTA pH8). 50µl of 100mg/ml 785 
lysozyme in 0.25M Tris was added and incubated at 37oC for 1 hour. 100ul of 786 
Proteinase K (18mg/ml),15µl of RNAase A (20mg/ml), 400µl of 0.5M EDTA (pH 8), 787 
and 250µl of 10% Sarkosyl were then added. This was left on ice for 2 hours and 788 
then incubated at 50oC. The DNA was then isolated by running through a gel, 789 
samples quantitated by qbit and pooled. Pooled DNA was sequenced on the Illumina 790 
Hiseq2500 platform. Inverse simpson (diversity) and chao (richness) of IgA-791 
opsonised bacteria was determined by using R package “microbiome”. 792 
 793 
Data availability 794 
Raw sequencing data files are available at ArrayExpress (accession numbers: E-795 
MTAB-8007, E-MTAB-8474, E-MTAB-8476, E-MTAB-8484 & E-MTAB-8486). 796 
Sequencing data for the microbiome are available at MGnify (ERS numbers are 797 
listed in Supplementary Table 2). Processed single-cell RNA sequencing object is 798 






1. Halfvarson, J. et al. Dynamics of the human gut microbiome in inflammatory 803 
bowel disease. Nat Microbiol 2, 17004 (2017). 804 
2. Donaldson, G. P., Melanie Lee, S. & Mazmanian, S. K. Gut biogeography of the 805 
bacterial microbiota. Nature Reviews Microbiology 14, 20–32 (2016). 806 
3. Zoetendal, E. G. et al. The human small intestinal microbiota is driven by rapid 807 
uptake and conversion of simple carbohydrates. ISME J. 6, 1415–1426 (2012). 808 
4. Cummings, J. H. & Macfarlane, G. T. The control and consequences of bacterial 809 
fermentation in the human colon. J. Appl. Bacteriol. 70, 443–459 (1991). 810 
5. Wang, X., Heazlewood, S. P., Krause, D. O. & Florin, T. H. J. Molecular 811 
characterization of the microbial species that colonize human ileal and colonic 812 
mucosa by using 16S rDNA sequence analysis. J. Appl. Microbiol. 95, 508–520 813 
(2003). 814 
6. Mowat, A. M. & Agace, W. W. Regional specialization within the intestinal 815 
immune system. Nat. Rev. Immunol. 14, 667–685 (2014). 816 
7. Denning, T. L. et al. Functional Specializations of Intestinal Dendritic Cell and 817 
Macrophage Subsets That Control Th17 and Regulatory T Cell Responses Are 818 
Dependent on the T Cell/APC Ratio, Source of Mouse Strain, and Regional 819 
Localization. The Journal of Immunology 187, 733–747 (2011). 820 
8. Atarashi, K. et al. Th17 Cell Induction by Adhesion of Microbes to Intestinal 821 
Epithelial Cells. Cell 163, 367–380 (2015). 822 
9. Ivanov, I. I. et al. Induction of intestinal Th17 cells by segmented filamentous 823 
bacteria. Cell 139, 485–498 (2009). 824 
10. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous 825 
Clostridium species. Science 331, 337–341 (2011). 826 
 
37 
11. Mazmanian, S. K., Liu, C. H., Tzianabos, A. O. & Kasper, D. L. An 827 
immunomodulatory molecule of symbiotic bacteria directs maturation of the host 828 
immune system. Cell 122, 107–118 (2005). 829 
12. Atarashi, K. et al. Ectopic colonization of oral bacteria in the intestine drives TH1 830 
cell induction and inflammation. Science 358, 359–365 (2017). 831 
13. Fanning, S. et al. Bifidobacterial surface-exopolysaccharide facilitates 832 
commensal-host interaction through immune modulation and pathogen 833 
protection. Proc. Natl. Acad. Sci. U. S. A. 109, 2108–2113 (2012). 834 
14. Bozorov, T. A., Rasulov, B. A. & Zhang, D. Characterization of the gut 835 
microbiota of invasive Agrilus mali Matsumara (Coleoptera: Buprestidae) using 836 
high-throughput sequencing: uncovering plant cell-wall degrading bacteria. Sci. 837 
Rep. 9, 4923 (2019). 838 
15. Consortium, T. H. M. P. & The Human Microbiome Project Consortium. 839 
Structure, function and diversity of the healthy human microbiome. Nature 486, 840 
207–214 (2012). 841 
16. Wu, G. D. et al. Linking long-term dietary patterns with gut microbial 842 
enterotypes. Science 334, 105–108 (2011). 843 
17. Jones, R. B. et al. Inter-niche and inter-individual variation in gut microbial 844 
community assessment using stool, rectal swab, and mucosal samples. Sci. 845 
Rep. 8, 4139 (2018). 846 
18. Smillie, C. S. et al. Rewiring of the cellular and inter-cellular landscape of the 847 
human colon during ulcerative colitis. (2018). doi:10.1101/455451 848 
19. Chakarov, S. et al. Two distinct interstitial macrophage populations coexist 849 
across tissues in specific subtissular niches. Science 363, (2019). 850 
20. Kumar, B. V. et al. Human Tissue-Resident Memory T Cells Are Defined by 851 
 
38 
Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites. 852 
Cell Rep. 20, 2921–2934 (2017). 853 
21. Cook, D. N. et al. CCR6 mediates dendritic cell localization, lymphocyte 854 
homeostasis, and immune responses in mucosal tissue. Immunity 12, 495–503 855 
(2000). 856 
22. Ward, S. Faculty of 1000 evaluation for Transcription factor KLF2 regulates the 857 
migration of naive T cells by restricting chemokine receptor expression patterns. 858 
F1000 - Post-publication peer review of the biomedical literature (2008). 859 
doi:10.3410/f.1103864.560997 860 
23. Toribio-Fernández, R. et al. Lamin A/C augments Th1 differentiation and 861 
response against vaccinia virus and Leishmania major. Cell Death Dis. 9, 9 862 
(2018). 863 
24. Mateyak, M. K. & Kinzy, T. G. eEF1A: thinking outside the ribosome. J. Biol. 864 
Chem. 285, 21209–21213 (2010). 865 
25. Lönnberg, T. et al. Single-cell RNA-seq and computational analysis using 866 
temporal mixture modelling resolves Th1/Tfh fate bifurcation in malaria. Sci 867 
Immunol 2, (2017). 868 
26. Miragaia, R. J. et al. Single-Cell Transcriptomics of Regulatory T Cells Reveals 869 
Trajectories of Tissue Adaptation. Immunity (2019). 870 
doi:10.1016/j.immuni.2019.01.001 871 
27. Miyao, T. et al. Plasticity of Foxp3 T Cells Reflects Promiscuous Foxp3 872 
Expression in Conventional T Cells but Not Reprogramming of Regulatory T 873 
Cells. Immunity 36, 262–275 (2012). 874 
28. Mucida, D. et al. Oral tolerance in the absence of naturally occurring Tregs. J. 875 
Clin. Invest. 115, 1923–1933 (2005). 876 
 
39 
29. Povoleri, G. A. M. et al. Human retinoic acid-regulated CD161 regulatory T cells 877 
support wound repair in intestinal mucosa. Nat. Immunol. 19, 1403–1414 878 
(2018). 879 
30. Schiering, C. et al. The alarmin IL-33 promotes regulatory T-cell function in the 880 
intestine. Nature 513, 564–568 (2014). 881 
31. Krzysiek, R. et al. Antigen receptor engagement selectively induces 882 
macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta 883 
chemokine production in human B cells. J. Immunol. 162, 4455–4463 (1999). 884 
32. Takahashi, K. et al. CCL3 and CCL4 are biomarkers for B cell receptor pathway 885 
activation and prognostic serum markers in diffuse large B cell lymphoma. 886 
British Journal of Haematology 171, 726–735 (2015). 887 
33. Burger, J. A. et al. High-level expression of the T-cell chemokines CCL3 and 888 
CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and 889 
after BCR stimulation. Blood 113, 3050–3058 (2009). 890 
34. Mencarelli, A. et al. Highly specific blockade of CCR5 inhibits leukocyte 891 
trafficking and reduces mucosal inflammation in murine colitis. Sci. Rep. 6, 892 
30802 (2016). 893 
35. Zhang, Y. et al. Plasma cell output from germinal centers is regulated by signals 894 
from Tfh and stromal cells. J. Exp. Med. 215, 1227–1243 (2018). 895 
36. Caraux, A. et al. Circulating human B and plasma cells. Age-associated 896 
changes in counts and detailed characterization of circulating normal CD138- 897 
and CD138 plasma cells. Haematologica 95, 1016–1020 (2010). 898 
37. Hieshima, K. et al. CC chemokine ligands 25 and 28 play essential roles in 899 
intestinal extravasation of IgA antibody-secreting cells. J. Immunol. 173, 3668–900 
3675 (2004). 901 
 
40 
38. Hu, K. et al. CCL19 and CCL28 Augment Mucosal and Systemic Immune 902 
Responses to HIV-1 gp140 by Mobilizing Responsive Immunocytes into 903 
Secondary Lymph Nodes and Mucosal Tissue. The Journal of Immunology 191, 904 
1935–1947 (2013). 905 
39. Mora, J. R. & von Andrian, U. H. Differentiation and homing of IgA-secreting 906 
cells. Mucosal Immunol. 1, 96 (2008). 907 
40. Zhang, W. et al. Characterization of the B Cell Receptor Repertoire in the 908 
Intestinal Mucosa and of Tumor-Infiltrating Lymphocytes in Colorectal Adenoma 909 
and Carcinoma. The Journal of Immunology 198, 3719–3728 (2017). 910 
41. Petrova, V. N. et al. Combined Influence of B-Cell Receptor Rearrangement and 911 
Somatic Hypermutation on B-Cell Class-Switch Fate in Health and in Chronic 912 
Lymphocytic Leukemia. Front. Immunol. 9, 1784 (2018). 913 
42. Macpherson, A. J. A Primitive T Cell-Independent Mechanism of Intestinal 914 
Mucosal IgA Responses to Commensal Bacteria. Science 288, 2222–2226 915 
(2000). 916 
43. Harbour, S. N., Maynard, C. L., Zindl, C. L., Schoeb, T. R. & Weaver, C. T. Th17 917 
cells give rise to Th1 cells that are required for the pathogenesis of colitis. Proc. 918 
Natl. Acad. Sci. U. S. A. 112, 7061–7066 (2015). 919 
44. Ferreira, R. C. et al. Cells with Treg-specific FOXP3 demethylation but low 920 
CD25 are prevalent in autoimmunity. J. Autoimmun. 84, 75–86 (2017). 921 
45. Hoffmann, P. et al. Loss of FOXP3 expression in natural human CD4+CD25+ 922 
regulatory T cells upon repetitive in vitro stimulation. Eur. J. Immunol. 39, 1088–923 
1097 (2009). 924 
46. Kyewski, B. & Suri-Payer, E. CD4+CD25+ Regulatory T Cells: Origin, Function 925 
and Therapeutic Potential. (Springer Science & Business Media, 2006). 926 
 
41 
47. Brandtzaeg, P. Function of mucosa-associated lymphoid tissue in antibody 927 
formation. Immunol. Invest. 39, 303–355 (2010). 928 
48. Meng, W. et al. An atlas of B-cell clonal distribution in the human body. Nat. 929 
Biotechnol. 35, 879–884 (2017). 930 
49. Dunn-Walters, D. K., Boursier, L. & Spencer, J. Hypermutation, diversity and 931 
dissemination of human intestinal lamina propria plasma cells. Eur. J. Immunol. 932 
27, 2959–2964 (1997). 933 
50. Tsuji, M. et al. Requirement for Lymphoid Tissue-Inducer Cells in Isolated 934 
Follicle Formation and T Cell-Independent Immunoglobulin A Generation in the 935 
Gut. Immunity 29, 261–271 (2008). 936 
51. van der Waaij, L. A., Limburg, P. C., Mesander, G. & van der Waaij, D. In vivo 937 
IgA coating of anaerobic bacteria in human faeces. Gut 38, 348–354 (1996). 938 
52. Imam, T., Park, S., Kaplan, M. H. & Olson, M. R. Effector T Helper Cell Subsets 939 
in Inflammatory Bowel Diseases. Front. Immunol. 9, 1212 (2018). 940 
53. Castro-Dopico, T. et al. Anti-commensal IgG Drives Intestinal Inflammation and 941 
Type 17 Immunity in Ulcerative Colitis. Immunity (2019). 942 
doi:10.1016/j.immuni.2019.02.006 943 
54. Cunningham-Rundles, C. Physiology of IgA and IgA deficiency. J. Clin. 944 
Immunol. 21, 303–309 (2001). 945 
55. Moon, C. et al. Vertically transmitted faecal IgA levels determine extra-946 
chromosomal phenotypic variation. Nature 521, 90–93 (2015). 947 
56. Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene 948 
expression data analysis. Genome Biol. 19, 15 (2018). 949 
57. Park, J.-E., Polański, K., Meyer, K. & Teichmann, S. A. Fast Batch Alignment of 950 
Single Cell Transcriptomes Unifies Multiple Mouse Cell Atlases into an 951 
 
42 
Integrated Landscape. doi:10.1101/397042 952 
58. Stuart, T. et al. Comprehensive Integration of Single-Cell Data. Cell 177, 1888–953 
1902.e21 (2019). 954 
59. Trapnell, C. et al. The dynamics and regulators of cell fate decisions are 955 
revealed by pseudotemporal ordering of single cells. Nature Biotechnology 32, 956 
381–386 (2014). 957 
60. Browne, H. P. et al. Culturing of ‘unculturable’ human microbiota reveals novel 958 
taxa and extensive sporulation. Nature 533, 543–546 (2016). 959 
61. Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K. & Schloss, P. D. 960 
Development of a dual-index sequencing strategy and curation pipeline for 961 
analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. 962 
Appl. Environ. Microbiol. 79, 5112–5120 (2013). 963 
62. Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2 – Approximately Maximum-964 
Likelihood Trees for Large Alignments. PLoS One 5, e9490 (2010). 965 
63. Letunic, I. & Bork, P. Interactive tree of life (iTOL) v3: an online tool for the 966 
display and annotation of phylogenetic and other trees. Nucleic Acids Res. 44, 967 
W242–5 (2016). 968 
64. Stubbington, M. J. T. et al. T cell fate and clonality inference from single-cell 969 
transcriptomes. Nat. Methods 13, 329–332 (2016). 970 
65. Bolotin, D. A. et al. MiXCR: software for comprehensive adaptive immunity 971 
profiling. Nat. Methods 12, 380–381 (2015). 972 
66. Nazarov, V. I. et al. tcR: an R package for T cell receptor repertoire advanced 973 
data analysis. BMC Bioinformatics 16, (2015). 974 
67. Heiden, J. A. V. et al. pRESTO: a toolkit for processing high-throughput 975 
sequencing raw reads of lymphocyte receptor repertoires. Bioinformatics 30, 976 
 
43 
1930–1932 (2014). 977 
68. Ye, J., Ma, N., Madden, T. L. & Ostell, J. M. IgBLAST: an immunoglobulin 978 
variable domain sequence analysis tool. Nucleic Acids Research 41, W34–W40 979 
(2013). 980 
69. Gupta, N. T. et al. Change-O: a toolkit for analyzing large-scale B cell 981 
immunoglobulin repertoire sequencing data. Bioinformatics 31, 3356–3358 982 
(2015). 983 
  984 
 
44 
Figure Legends:  985 
 986 
Figure 1: Profiling immune cells along the steady-state colon. a) Workflow for 987 
16S ribosomal sequencing of matching mucosal microbiomes (n=12 donors) and 988 
scRNA-seq profiling of immune cells from mesenteric lymph node (mLN), and lamina 989 
propria of caecum, transverse colon and sigmoid colon (n=6 donors). b) 990 
Phylogenetic tree representing diversity and mean abundance of bacterial species in 991 
the caecum, transverse colon and sigmoid colon. Mean abundance was calculated 992 
as the percentage of OTU for each species from total as determined by 16S 993 
ribosomal sequencing and averaged for twelve donors (black scale). Unassigned 994 
OTUs are shown as black branches. Bacteria groups of interest are highlighted. c) 995 
Relative abundances of OTUs at genus level of bacteria species in colon as in b. d) 996 
Clustering of pooled immune cells visualised in a UMAP plot coloured by tissue of 997 
origin (left) and cell type annotation (right). e) Mean expression level and percentage 998 
of cells expressing marker genes used to annotate clusters in d. f) Relative 999 
percentages of CD4+ T subpopulations within all CD4+ T cells for each tissue as in d. 1000 
g) Relative percentages of cell types within all non-CD4+ T immune cells for each 1001 
tissue as in d, with B cells shown in the left panel and all other cell types in the right 1002 
panel.  1003 
 1004 
Figure 2: Dissemination of T helper cells in colon and region-determined 1005 
transcriptional profiles. a) Correlation matrix of mean transcriptional profiles of Th1 1006 
and Th17 cells from caecum, transverse colon, sigmoid colon and mLN (n=5 1007 
donors). b) Mean expression level of differentially expressed genes of T helper cells 1008 
between caecum, transverse colon and sigmoid colon. c) UMAP projection of 1009 
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Smartseq2 profiled Th1 and Th17 cells of the caecum, transverse colon and sigmoid 1010 
colon (n=1 donor). Colour lines connect cells sharing the same CDR3 sequence. d) 1011 
Heatmap of numbers of members within clonal families in Th1/Th17 subsets (left) 1012 
and colon region (right).  1013 
 1014 
Figure 3: Treg activation pathway from lymphoid to peripheral tissue. a) UMAP 1015 
visualisation of Treg subtypes in mLN (left) and colonic regions (right) (n=5 donors). 1016 
b) Relative proportions of Treg subsets within all Treg cells from mLN and colon 1017 
tissue regions. Bars show mean proportion across all donors (circles). c) Density of 1018 
Treg subclusters as in a across ‘pseudospace’ (top) and expression kinetics of 1019 
genes contributing to pseudospace smoothed into 100 bins (filtered by qval < 0.001 1020 
and expression in >15 cells). Top bar shows most represented tissue within each 1021 
bin. Various dynamically expressed immune-related molecules are annotated, with 1022 
key genes coloured red. 1023 
 1024 
Figure 4: B cells are more abundant, clonal expanded and mutated in the 1025 
sigmoid colon. a) Log normalised mean transcript counts of key differentially 1026 
expressed activation and tissue-migration genes by IgA+ plasma cells in caecum, 1027 
transverse colon and sigmoid colon (n=5 donors). b) Proportion of CD27+ B cells of 1028 
total B cells from colon regions determined by flow cytometry (n=4 donors). Bar 1029 
represents mean proportion and connected points represents values of each donor. 1030 
Analysis is a two-tailed paired t test. c) Clustering of B cells for which matched 1031 
single-cell VDJ libraries were derived using 10x Genomics 5’ scRNA-seq (n=2 1032 
donors). B cells are visualised by UMAP projection coloured by cell type annotation 1033 
(left), tissue of origin (middle) and antibody isotype (right). Antibody isotype 1034 
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frequencies per annotated cell type across both donors are depicted as a bar plot 1035 
(far right). d) Somatic hypermutation frequencies of single-cell VDJ-derived IgH 1036 
sequences as in c. e) Quantitation of somatic hypermutation frequencies of single-1037 
cell VDJ-derived IgH sequences from B cell types and gut regions. f) Estimated 1038 
clonal abundances per donor for members of expanded B cell clones in B cell types 1039 
and gut regions. g) Co-occurrence of expanded B cell clones identified by single-cell 1040 
VDJ analysis shared across colon regions as in c. Numbers reflect binary detection 1041 
event rather than the number of members per clone shared. h) Co-occurrence of 1042 
expanded B cell clones identified by bulk B cell receptor (BCR) sequencing shared 1043 
across mLN, caecum, transverse colon and sigmoid colon (n=3 donors). Rows and 1044 
columns in g and h are ordered by hierarchical clustering.  1045 
 1046 
Figure 5: Increasing number of microbiome species recognised by antibodies 1047 
in the sigmoid colon. a) Experimental workflow for assessing Ig-opsonised colon 1048 
bacterial species. b) Representative histogram of IgA1/2-bound Hoechst+ bacteria 1049 
and summary plot of bound bacteria as a proportion of total bacteria (n=13 donors). 1050 
Positive binding is set against an isotype control. c) Richness of bacteria species 1051 
determined as the number of unique species and d) diversity of species identified 1052 
from shotgun sequencing of Ig-opsonised bacteria from b (n=6 donors). e) Summary 1053 
schematic showing proximal-to-distal increasing in accumulation, targeted migration, 1054 
clonal expansion and mutation frequency of IgA+ plasma cell, and associated 1055 
increasing diversity of reactive bacteria. P values were calculated using two-tailed 1056 
paired ANOVA with multiple comparisons (b) and one-tailed paired ANOVA with 1057 




Supplementary Figure 1: Single-cell mapping of immune cells in the steady-1060 
state human colon.  1061 
 a) Shannon diversity score of bacterial OTUs from mucosa surfaces of the caecum, 1062 
transverse colon and sigmoid colon (n=12 donors). b) Relative abundances of OTUs 1063 
at phylum level as in a. c) Relative abundances of Bacteroides, Coprobacillus, 1064 
Shigella and Enterococcus spp. in colon regions as in a, with lines connecting 1065 
samples from each donor. d) Flow cytometry-sorting strategy for single, live, CD45+, 1066 
CD3-, CD4- immune cells (red) and single, live, CD45+, CD3+, CD4+ T cells (blue) 1067 
from mLN (top) and colon lamina propria (bottom). e) UMAP projection of all cells 1068 
after filtering and QC (as in Figure 1d & 1e), with the five donors represented as 1069 
different colours. b & c) Bars show mean proportion in each region and statistical 1070 
significances are calculated from 2-way ANOVA with Tukey’s multiple corrections of 1071 
the total OTU dataset. * P <0.05; ** P <0.01; **** P <0.0001 1072 
 1073 
Supplementary Figure 2: Defining T helper cell transcriptional signatures in the 1074 
colon. 1075 
a) Heatmap of differentially expressed genes with filtering of 0.25 log fold change 1076 
and minimum percent expression of 10%between Th1 and Th17 cells pooled from 1077 
caecum, transverse colon and sigmoid colon (n=5 donors). Rows are ordered by 1078 
hierarchical clustering and columns are grouped by cell type as denoted in the 1079 
column annotation. 1080 
 1081 
Supplementary Figure 3: Treg subsets form a lymphoid-to-periphery activation 1082 
trajectory.  1083 
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a) Log mean expression level and percentage of marker genes used to annotate 1084 
Treg subsets in mLN and colon (n=5 donors). Gradient bar represents shift in 1085 
function of marker genes. b) tSNE projection of clustering of Treg subsets and 1086 
conventional CD4+ T cells of mLN and colon dataset. 1087 
 1088 
Supplementary Figure 4: Characterising B cell phenotypes and BCR 1089 
expression in mLN and colon regions. 1090 
a) BCR diversity rarefaction analysis of IgA+ plasma cell clones across multiple 1091 
diversity orders (Q) using single-cell VDJ-derived IgH sequences (n=2 donors). This 1092 
reveals comparable diversity between donors. b) Same as in a), but expanded IgA+ 1093 
plasma cell clones from both donors were pooled and were instead separated by gut 1094 
regions for BCR diversity rarefaction analysis (upper panel). Lower panels represent 1095 
the results from significance tests of the diversity index between gut regions at either 1096 
Q = 0 (left; corresponding to species richness measure) or Q = 1 (right; 1097 
corresponding to the exponential of the Shannon-Weiner index). c) Co-occurrence of 1098 
expanded B cell clones identified by single-cell VDJ analysis that are shared across 1099 
different gut regions and between different cell types. Numbers reflect a binary 1100 
detection event rather than the number of members per clone shared. d) Frequency 1101 
of variable and joining BCR sequence expression in mLN and colon regions, 1102 
detected by bulk BCR sequencing (n=3 donors). Rows are ordered by hierarchical 1103 
clustering.  1104 
Supplementary Table 1: Metadata of deceased transplant donors involved in 1105 
this study 1106 
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ID Sex Age Death Approx. 
BMI 
CMV/EBV Antibiotics prescribed 
within 2 weeks of death 




290b F 60-64 DBD 28 CMV+/EBV+  
296c F 35-40 DCD 21 CMV-/EBV+ Tazocin  
298c M 55-60 DCD 24 CMV-/EBV+  
302c M 40-44 DCD 35 CMV-/EBV-  
312c M 75-80 DCD 24 CMV+/EBV+  
362c M 60-65 DCD 27 CMV-/EBV+  
364b M 50-55 DBD 26 CMV-/EBV+  
367b M 65-70 DBD 25 CMV+/EBV+  
390c F 65-70 DCD 35 CMV+/EBV+  
403c M 50-55 DCD 33 CMV+/EBV+ Tazocin 
411c M 25-30 DCD 25 CMV+/EBV+ Meropenem 
414c M 50-55 DCD 30 CMV-/EBV+  
417c M 65-70 DCD 25 CMV-/EBV+  
 1107 
 1108 





